SFTPD and pulmonary fibrosis: Out of the typical HRCT characteristics of intrathoracic sarcoidosis, hilar and mediastinal lymph node enlargement, perilymphatic/peribronchovascular involvement, predominantly ground-glass lesions, and pulmonary fibrosis have shown differences in the measured serum markers, especially SAA, CA15.3, and SP-D.